Prospective cohort study finds hybrid-care improves clinical outcomes in inflammatory bowel disease, suggesting enhanced disease management.
Key Points
This study aims to evaluate the effectiveness of a hybrid-care program in improving clinical outcomes for patients with inflammatory bowel disease (IBD).
Conducted a 12-month prospective cohort study
Included adult patients with IBD participating in a hybrid-care program
Integrated mobile application and monthly electronic patient-reported outcome measures (PROMs)
Compared patient outcomes with a propensity-score-matched historical cohort
Treatment failure was significantly lower in the hybrid-care program (21.5%) compared to historical cohort (46.9%)
IBD-related hospitalizations were less frequent in hybrid-care participants (7.5%) than historical cohort (17.1%)
Monthly IBD-specific PROMs demonstrated strong associations with treatment failure, with AUC values ranging from 0.77 to 0.80
Digital step count metrics showed weak associations with treatment failure and poor discriminatory ability (AUC = 0.62)